Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 6
1997 1
1998 4
1999 6
2000 1
2001 4
2002 2
2003 5
2004 2
2005 3
2006 2
2007 1
2008 4
2009 4
2012 6
2013 7
2014 14
2015 17
2016 13
2017 8
2018 5
2019 8
2020 12
2021 10
2022 17
2023 19
2024 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

177 results

Results by year

Filters applied: . Clear all
Page 1
Editorial Comment.
Kocjancic E, Acar O. Kocjancic E, et al. Among authors: acar o. J Urol. 2022 Feb;207(2):415. doi: 10.1097/JU.0000000000002203.01. Epub 2021 Nov 16. J Urol. 2022. PMID: 34781693 No abstract available.
AUTHORS' REPLY.
Acar O, Dobbs RW, Kocjancic E. Acar O, et al. Urology. 2020 Apr;138:173. doi: 10.1016/j.urology.2019.11.045. Urology. 2020. PMID: 32252950 No abstract available.
Re: Khullar V, Lemmon B, Acar O, Abrams P, Vahabi B Does COVID-19 Cause or Worsen LUT Dysfunction, What Are the Mechanisms and Possible Treatments? ICI-RS 2023. Neurourol Urodyn 2024 Aug;43(6):1458-1463. doi: 101002/nau25441. Epub 2024 Mar 20. PMID: 38506116.
Khullar V, Lemmon B, Acar Ö, Abrams P, Vahabi B. Khullar V, et al. Among authors: acar o. Neurourol Urodyn. 2024 Nov 13. doi: 10.1002/nau.25609. Online ahead of print. Neurourol Urodyn. 2024. PMID: 39535296 No abstract available.
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer.
Kahraman S, Erul E, Seyyar M, Gumusay O, Bayram E, Demirel BC, Acar O, Aksoy S, Baytemur NK, Sahin E, Cabuk D, Basaran G, Paydas S, Yaren A, Guven DC, Erdogan AP, Demirci U, Yasar A, Bayoglu İV, Hizal M, Gulbagci B, Paksoy N, Davarci SE, Yilmaz F, Dogan O, Orhan SO, Kayikcioglu E, Aytac A, Keskinkilic M, Mocan EE, Unal OU, Aydin E, Yucel H, Isik D, Eren O, Uluc BO, Ozcelik M, Hacibekiroglu I, Aydiner A, Demir H, Oksuzoglu B, Cilbir E, Cubukcu E, Cetin B, Oktay E, Erol C, Okutur SK, Yildirim N, Alkan A, Selcukbiricik F, Aksoy A, Karakas Y, Ozkanli G, Duman BB, Aydin D, Dulgar O, Er MM, Teker F, Yavuzsen T, Aykan MB, Inal A, Iriagac Y, Kalkan NO, Keser M, Sakalar T, Menekse S, Kut E, Bilgin B, Karaoglanoglu M, Sunar V, Ozdemir O, Turhal NS, Karadurmus N, Yalcin B, Sendur MAN. Kahraman S, et al. Among authors: acar o. Future Oncol. 2023 Mar;19(10):727-736. doi: 10.2217/fon-2022-1287. Epub 2023 May 3. Future Oncol. 2023. PMID: 37133230
177 results